Vassiliki Magafa

Comparison of the solution structures of angiotensin I & II

Georgios A. Spyroulias, Panagiota Nikolakopoulou, Andreas G. Tzakos et al. · European Journal of Biochemistry · 2003 · 48 citations

Computational Chemistry, Spectra-structure Correlation, Molecular Pharmacology +16

Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination

Sophie Tourdot, Mohamed Oukka, Jean‐Claude Manuguerra et al. · The Journal of Immunology · 1997 · 46 citations

Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolin

Constantinos M. Mikelis, Katerina Theochari, Dionussios Vourtsis et al. · Vascular Cell · 2012 · 44 citations · Full text

Substance P C-terminal octapeptide analogues augment tumor necrosis factor-α release by human blood monocytes and macrophages

Wen‐Zhe Ho, George Stavropoulos, Jianping Lai et al. · Journal of Neuroimmunology · 1998 · 37 citations

Inflammation, Cytokine, Anti-inflammatory +8

Electronic Sculpting of Ligand-GPCR Subtype Selectivity: The Case of Angiotensin II

Francesca Magnani, Charalampos G. Pappas, Tim Crook et al. · ACS Chemical Biology · 2014 · 32 citations · Full text

Ligand-gpcr Subtype Selectivity, Engineering, Chemoprevention Strategy +23